Assessment of Medication Adherence and Health-Related Quality of Life in Chronic Liver Disease Patients

Sudhamshu K Tantry; Ruhana; Mary Daborah; Amal Mathew; Noah M Bose

Sudhamshu K Tantry ⁽¹⁾ , Ruhana ⁽²⁾ , Mary Daborah ⁽³⁾ , Amal Mathew ⁽⁴⁾ , Noah M Bose ⁽⁵⁾

(1) Department of Pharmacy Practice, Karavali College of Pharmacy, Mangalore-575028, Karnataka, India, India ,

(2) Department of Pharmacy Practice, Karavali College of Pharmacy, Mangalore-575028, Karnataka, India, India ,

(3) Department of Pharmacy Practice, Karavali College of Pharmacy, Mangalore-575028, Karnataka, India, India ,

(4) Department of Pharmacy Practice, Karavali College of Pharmacy, Mangalore-575028, Karnataka, India, India ,

(5) Department of Pharmacy Practice, Karavali College of Pharmacy, Mangalore-575028, Karnataka, India, India

Issue
Vol. 12 No. 4 (2021): Volume 12 Issue 4

Keywords:

Chronic Liver Disease, Medication Adherence, Health Related Quality of Life, RAND’s SF-36 Quality of Life Questionnaire, Adherence to medication and refills scale, Child-Turcotte-Pugh Score

PDF LaTeX HTML ePUB

Abstract

Cirrhosis is a growing cause of morbidity and mortality in developed countries. It is associated with multiple life-threatening complications. Improving medication adherence could have a greater impact on the health of the population. Health-Related Quality of Life (HRQoL) has become a common outcome indicator in clinical and epidemiological studies. It is a multidimensional concept that includes self-reported measures of one's physical and mental health as well as their social well-being. This study aimed to assess the HRQoL and medication adherence in Chronic Liver Disease (CLD) patients. Medication adherence was determined using the Adherence to Refills and Medication Scale (ARMS) and RAND's SF-36 was used to assess HRQoL. A total of 102 Chronic Liver Disease patients were enrolled in the study, the majority of whom belonged to Child-Turcotte-Pugh class C (45.1%). The majority of the patients had a history of alcohol consumption (77.5%). The total average of four dimensions under PCS and MCS of SF-36 was 45.49 and 72.89 respectively and the overall average of all domains was 59.19. Concerning the Child-Turcotte-Pugh score of the patients, a significant correlation was obtained between physical functioning and RLPH domains. ARMS score had a significant impact on 3 of the PCS and all MCS domains of SF-36, indicating that the patient's medication adherence has an important role in HRQoL.

Full text article

Generated from XML file

References

Afendy, A., Kallman, J. B., Stepanova, M., Younoszai, Z., Aquino, R. D., Bianchi, G., Marchesini, G., Younossi, Z. M. 2009. Predictors of health-related quality of life in patients with chronic liver disease. Alimentary Pharmacology and Therapeutics, 30(5):469–476.

Arguedas, M. R., Delawrence, T. G., Mcguire, B. M. 2003. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Digestive Diseases and Sciences, 48(8):1622–1626.

Benegal, V., Gururaj, G., Murthy, P. 2003. Report on a WHO collaborative project on unrecorded consumption of alcohol in Karnataka, India. pages 1–5. Accessed On: 05 Jan 2021.

Brown, M. T., Bussell, J., Dutta, S., Davis, K., Strong, S., Mathew, S. 2016. Medication Adherence: Truth and Consequences. The American Journal of the Medical Sciences, 351(4):387–399.

Burge, S., White, D., Bajorek, E., Bazaldua, O., Trevino, J., Albright, T., Wright, F., Cigarroa, L. 2005. Correlates of medication knowledge and Adherence: findings from the residency research network of South Texas. Family Medicine, 37(10):712–718.

Claxton, A. J., Cramer, J., Pierce, C. 2001. A systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics, 23(8):1296–1310.

Conn, V. S., Ruppar, T. M. 2017. Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis. Preventive Medicine, 99:269–276.

Fedeli, U., Avossa, F., Ferroni, E., De Paoli, A., Donato, F., Corti, M. C. 2019. Prevalence of chronic liver disease among young/middle-aged adults in Northern Italy: role of hepatitis B and hepatitis C virus infection by age, sex ethnicity. Heliyon, 5(7):2114.

Häuser, W., Holtmann, G., Grandt, D. 2004. Determinants of health-related quality of life in patients with chronic liver diseases. Clinical Gastroenterology and Hepatology, 2(2):157–163.

Hayward, K. L., Valery, P. C., Cottrell, W. N., Irvine, K. M., Horsfall, L. U., Tallis, C. J., Chachay, V. S., Ruffin, B. J., Martin, J. H., Powell, E. E. 2016. Prevalence of medication discrepancies in patients with cirrhosis: a pilot study. BMC Gastroenterology, 16(1).

Hayward, K. L., Valery, P. C., Martin, J. H., Karmakar, A., Patel, P. J., Horsfall, L. U., Tallis, C. J., Stuart, K. A., Wright, P. L., Smith, D. D., Irvine, K. M., Powell, E. E., Cottrell, W. N. 2017. Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis. World Journal of Gastroenterology, 23(40):7321–7331.

Iredale, J. P. 2003. Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ, 327(7407):143–147.

Kim, H. J., Chu, H., Lee, S. 2018. Factors influencing on health-related quality of life in South Korean with chronic liver disease. Health and Quality of Life Outcomes, 16(1):142.

Kripalani, S., Risser, J., Gatti, M. E., Jacobson, T. A. 2009. Development and Evaluation of the Adherence to Refills and Medications Scale (ARMS) among Low-Literacy Patients with Chronic Disease. Value in Health, 12(1):118–123.

Mann, R. E., Smart, R. G., Govoni, R. 2003. The epidemiology of alcoholic liver disease. Alcohol Research and Health, 27(3):209–219.

Marchesini, G., Bianchi, G., Amodio, P., Salerno, F., Merli, M., Panella, C., Loguercio, C., Apolone, G., Niero, M., Abbiati, R. 2001. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology, 120(1):170–178.

Moon, A. M., Singal, A. G., Tapper, E. B. 2020. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clinical Gastroenterology and Hepatology, 18(12):2650–2666.

Morisky, D. E., Ang, A., Krousel-Wood, M., Ward, H. J. 2008. Predictive Validity of a Medication Adherence Measure in an Outpatient Setting. The Journal of Clinical Hypertension, 10(5):348–354.

Orr, J. G., Homer, T., Ternent, L., Newton, J., Mcneil, C. J., Hudson, M., Jones, D. E. J. 2014. Health related quality of life in people with advanced chronic liver disease. Journal of Hepatology, (5):1158–1165.

Park, H. Y., Seo, S. A., Yoo, H., Lee, K. 2018. Medication adherence and beliefs about medication in elderly patients living alone with chronic diseases. Patient Preference and Adherence, 12:175–181.

Patton, D. E., Hughes, C. M., Cadogan, C. A., Ryan, C. A. 2017. Theory-Based Interventions to Improve Medication Adherence in Older Adults Prescribed Polypharmacy: A Systematic Review. Drugs and Aging, 34(2):97–113.

Polis, S., Zang, L., Mainali, B., Pons, R., Pavendranathan, G., Zekry, A., Fernandez, R. 2016. Factors associated with medication adherence in patients living with cirrhosis. Journal of Clinical Nursing, 25(1-2):204–212.

Sempokuya, T., Zhang, G., Nakagawa, K. 2019. Temporal trends of cirrhosis associated conditions. World Journal of Hepatology, 11(1):74–85.

Sobhonslidsuk, A. 2006. Factors influencing health-related quality of life in chronic liver disease. World Journal of Gastroenterology, 12(48):7786.

Tsochatzis, E. A., Bosch, J., Burroughs, A. K. 2014. Liver cirrhosis. The Lancet, 383:60121–60126. Accessed On: May 17, 2014.

Vaz, J., Eriksson, B., Strömberg, U., Buchebner, D., Midlöv, P. 2020. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study. BMC Gastroenterology, 20(1).

Volk, M. L., Tocco, R. S., Bazick, J., Rakoski, M. O., Lok, A. S. 2012. Hospital re-admissions among patients with decompensated cirrhosis. The American journal of gastroenterology, 107(2):247–252.

Younossi, Z., Henry, L. 2015. Overall health-related quality of life in patients with end-stage liver disease. Clinical Liver Disease, 6(1):9–14.

Younossi, Z. M., Boparai, N., Price, L. L., Kiwi, M. L., Mccormick, M., Guyatt, G. 2001. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. American Journal of Gastroenterology, 96(7):2199–2205.